跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CY-09
首页
药物
CY-09
CY-09
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of inflammasome inhibitor CY-09 in preparation of medicine for treating non-alcoholic steatohepatitis
CN 111419842 A
申请人: NANFANG HOSPITAL SOUTHERN MEDICAL UNIV
优先权: 2020
CN
Application of CY-09 in preparation of reagent for preventing postoperative recurrence of non-alcoholic fatty liver diseases
CN 111481545 A
申请人: NANFANG HOSPITAL SOUTHERN MEDICAL UNIV
优先权: 2020
CN
Application of CY-09 in preparation of medicine for resisting joint prosthesis wear particle induced osteolysis
CN 112245427 A
申请人: SHANGHAI GENERAL HOSPITAL
优先权: 2020
CN
一种用于治疗阿尔兹海默症的微针贴片及其制备方法
CN 114191376 B
申请人: 中国药科大学
优先权: 2022
CN
一种冬凌草甲素衍生物及其制备方法和医用用途
CN 114874172 B
申请人: 庞磊
优先权: 2022
CN
Application of CY-09 in preparation of medicine for preventing, improving and/or treating night noise induced hearing loss
CN 120053437 A
申请人: SHANGHAI 9TH PEOPLES HOSPITAL SHANGHAI JIAOTONG UNIV SCHOOL MEDICINE
优先权: 2023
CN
New application of inflammasome inhibitor CY-09 in treatment of post-myocardial infarction inflammation and ventricular remodeling
CN 119386011 A
申请人: UNIV SOUTHEAST
优先权: 2024
CN
一种调控缺血微环境的工程化血小板膜纳米载体及其制备方法
CN 119868305 B
申请人: 河北工业大学
优先权: 2025
CN
NLRP3 inflammasome inhibitor coupled with hydrogen sulfide donor as well as preparation method and application of NLRP3 inflammasome inhibitor
CN 120136808 A
申请人: UNIV XUZHOU MEDICAL
优先权: 2025
CN
CY-09-loaded albumin nanoparticles as well as preparation method and application thereof
CN 120093696 A
申请人: WEST CHINA HOSPITAL SICHUAN UNIV
优先权: 2025
CN
第 1 / 2 页
上一页
下一页
药物
反馈